Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM).
Devergie A, Blaise D, Attal M, Tigaud JD, Jouet JP, Vernant JP, Bordigoni P, Ifrah N, Dauriac C, Cahn JY, et al. Devergie A, et al. Blood. 1995 Apr 15;85(8):2263-8. Blood. 1995. PMID: 7718899 Free article. Clinical Trial.
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A. Devergie A, et al. Bone Marrow Transplant. 1997 Jul;20(1):11-9. doi: 10.1038/sj.bmt.1700844. Bone Marrow Transplant. 1997. PMID: 9232250
Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.
Sutton L, Kuentz M, Cordonnier C, Blaise D, Devergie A, Guyotat D, Leblond V, Flesch M, Bordigoni P, Attal M, et al. Sutton L, et al. Among authors: devergie a. Bone Marrow Transplant. 1993 Dec;12(6):583-9. Bone Marrow Transplant. 1993. PMID: 8136742 Clinical Trial.
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A. van Rhee F, et al. Among authors: devergie a. Bone Marrow Transplant. 1997 Oct;20(7):553-60. doi: 10.1038/sj.bmt.1700933. Bone Marrow Transplant. 1997. PMID: 9337056 Free article.
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse.
Blaise D, Maraninchi D, Archimbaud E, Reiffers J, Devergie A, Jouet JP, Milpied N, Attal M, Michallet M, Ifrah N, et al. Blaise D, et al. Among authors: devergie a. Blood. 1992 May 15;79(10):2578-82. Blood. 1992. PMID: 1586710 Free article. Clinical Trial.
Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO).
Socie G, Devergie A, Girinsky T, Reiffers J, Vernant JP, Le Bourgeois JP, Herve P, Guyotat D, Maraninchi D, Rio B, et al. Socie G, et al. Among authors: devergie a. Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):397-404. doi: 10.1016/0360-3016(91)90048-9. Int J Radiat Oncol Biol Phys. 1991. PMID: 1995523
213 results